SARS-CoV-2 Infection and Rates of Neonatal Congenital Anomalies - Takeaways - MDSpire

SARS-CoV-2 Infection and Rates of Neonatal Congenital Anomalies

  • By

  • John W. Snelgrove

  • Rinku Sutradhar

  • Nancy N. Baxter

  • Karl Everett

  • Stephanie C. Lapinsky

  • Douglas M. Campbell

  • Mark H. Yudin

  • Howard Berger

  • Eliane M. Shore

  • Andrea N. Simpson

  • May 7, 2026

  • 0 min

Share

  • 1

    The study investigates the association between maternal SARS-CoV-2 infection during pregnancy and neonatal congenital anomalies in Ontario.

  • 2

    Previous research indicated no significant effects of COVID-19 on preterm birth, stillbirth, or severe maternal morbidity in Ontario.

  • 3

    The study employs a matched cohort design, comparing live births with maternal SARS-CoV-2 infection to those without.

  • 4

    Congenital anomalies occur in approximately 3% of births, with infections contributing to a small proportion of these defects.

  • 5

    Further research is needed to clarify potential teratogenic effects of SARS-CoV-2 based on the timing of maternal infection.

Original Source(s)

SARS-CoV-2 Infection and Rates of Neonatal Congenital Anomalies

  • by John W. Snelgrove, Rinku Sutradhar, Nancy N. Baxter, Karl Everett, Stephanie C. Lapinsky, Douglas M. Campbell, Mark H. Yudin, Howard Berger, Eliane M. Shore, Andrea N. Simpson

  • May 7, 2026

Related Content

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

The Care Continuum of Patients With Influenza in the Post–COVID-19 Era: A Position Paper